Shaw, K. J., Schell, W. A., Covel, J., Duboc, G., Giamberardino, C., Kapoor, M., … Perfect, J. R. (2018). In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(8). https://doi.org/10.1128/ACC00523;e00523-18

Shaw, Karen Joy, Wiley A. Schell, Jonathan Covel, Gisele Duboc, C. Giamberardino, Mili Kapoor, Molly Moloney, et al. “In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus.” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 62, no. 8 (August 1, 2018). https://doi.org/10.1128/ACC00523;e00523-18.

Shaw KJ, Schell WA, Covel J, Duboc G, Giamberardino C, Kapoor M, et al. In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018 Aug 1;62(8).

Shaw, Karen Joy, et al. “In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus.” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 62, no. 8, AMER SOC MICROBIOLOGY, Aug. 2018. Wos, doi:10.1128/ACC00523;e00523-18.

Shaw KJ, Schell WA, Covel J, Duboc G, Giamberardino C, Kapoor M, Moloney M, Soltow QA, Tenor JL, Toffaletti DL, Trzoss M, Webb P, Perfect JR. In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. AMER SOC MICROBIOLOGY; 2018 Aug 1;62(8).